Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Early Onset Type 1 Diabetes
NCT01280682Phase 4Completed
- Start
- Jul 2010
- Primary completion
- Dec 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in type 1 diabetes mellitus (T1D). Started Jul 2010; status: completed.
02
Drugs
rituximab
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01280682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01280682.